Terray Therapeutics · 1 month ago
Scientist, In Vivo Pharmacology
United States
Full-time
Remote
Senior Level
$120K/yr - $175K/yr
3+ years expTerray Therapeutics is a venture-backed biotechnology company focused on transforming drug discovery and development. They are seeking a highly motivated in vivo scientist with expertise in autoimmunity and inflammation to lead outsourced pharmacology studies, ensuring scientific rigor and cross-functional collaboration.
Artificial Intelligence (AI)PharmaceuticalBiotechnologyLife ScienceHealthcareBiopharmaMedical
Responsibilities
Provide scientific leadership and oversight for in vivo pharmacology studies focused on inflammation, autoimmunity, or related therapeutic areas in support of advancing our pipeline programs
As the pharmacology representative, collaborate cross-functionally with preclinical teams, project leads, and external consultants to advance our pipeline programs through in vivo studies
Lead and monitor outsourced in vivo pharmacology and nonclinical safety/toxicity studies conducted at CROs, ensuring scientific rigor, protocol compliance, data quality, and timely execution
Contribute to study design, protocol development and review, endpoint selection and data interpretation
Review study reports, datasets and summaries to ensure scientific accuracy and completeness
Coordinate study timelines, logistics, milestones, budgets and deliverables across multiple external vendors and internal stakeholders
Manage CRO relationships, including vendor selection, performance oversight, issue resolution and communication
Maintain study documentation, ensuring compliance with regulatory requirements and company policies
Present study updates and recommendations to project teams and leads
Support contract management activities (scopes of work, purchase orders, invoice tracking)
Qualification
Required
Ph.D. degree in biology, immunology, pharmacology, toxicology, or a related field
3+ years of experience in biotech or pharmaceutical industry supporting nonclinical drug development programs
Strong scientific background in inflammation, immunology, or immune-related diseases
Extensive experience with rodent in vivo pharmacology and translational disease models
Strong scientific data analysis, interpretation, and problem-solving skills
Strong understanding of nonclinical drug development workflow
Experience managing or monitoring outsourced studies at CROs
Demonstrated project management and organizational skills with the ability to manage multiple studies and priorities simultaneously
Excellent written, verbal, and presentation skills
Ability to work effectively in cross-functional teams and to thrive in a highly collaborative research environment
Preferred
Experience with vendor oversight, contract management, and budget tracking
Experience supporting IND-enabling and preclinical development programs
Knowledge of GLP and non-GLP study conduct and non-clinical assessment
Familiarity with IACUC regulations and animal welfare standards
Benefits
Participation in the Company’s stock option plan
A 3% retirement safe harbor contribution
Fully paid health, dental, vision insurance for our employees, spouse, partner and families
Above-market life insurance
Disability coverage
Company
Terray Therapeutics
Terray Therapeutics is a biotechnology company that transforms small molecule drug discovery.
51-200 employees
H1B Sponsorship
Terray Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
100%
Represents job field similar to this job
Engineering and Development
Trends of Total Sponsorships
*2025 (1)
2024 (1)
2022 (1)
Funding
Current Stage
Growth StageTotal Funding
$225MKey Investors
Silicon Valley BankBedford Ridge Capital,NVenturesNVentures
2025-04-01Debt Financing· $25M
2024-10-17Series B· $120M
2023-11-09Series Unknown
Leadership Team
Eli Berlin
Co-Founder
Narbe Mardirossian
Chief Technology Officer
Recent News
2026-06-15
Two Sigma Ventures
2026-03-13
Genetic Engineering News
2026-02-16
Company data provided by crunchbase